China’s biotech rise, Healthcare Today

Partners Emmanuelle Trombe and Anthony Paronneau co-authored a Healthcare Today article examining China’s rise as a global biotechnology innovation hub and the opportunities it presents for life sciences companies.

They explore cross-border collaboration models and key considerations for China-related transactions, including intellectual property, regulatory compliance, data management, and foreign investment screening.

Read the full Healthcare Today article >>